MENU
RDNT
AS OF
Feb 4, 04:59 PM (EDT)
Price
$67.68
Change
-$2.43 (-3.47%)
Capitalization
5.42B
27 days until earnings call
Intraday BUY SELL Signals

RDNT Stock RadNet (RDNT, $71.66) Moving Average Convergence Divergence (MACD) Histogram turned negative on January 28, 2026

A.I.dvisor
at Tickeron.com
Loading...
RDNT - RadNet
MACD signal
Bearish Trend
Odds of DOWN Trend
Tickeron
MACD signal
Price: $71.66
Daily change: -$0.84 (-1.16%)
Daily volume: 457.4K
Capitalization: $5.5B
Industry: Medical Specialties

This is a Bearish indicator signaling RDNT's price could decline from here. Traders may explore shorting the stock or put options. A.I. dvisor identified 55 similar cases where RDNT's MACD histogram became negative, and of them led to successful outcomes. Odds of Success:

RDNT sees MACD Histogram just turned negative

RDNT saw its Moving Average Convergence Divergence Histogram (MACD) turn negative on January 28, 2026. This is a bearish signal that suggests the stock could decline going forward. Tickeron's A.I.dvisor looked at 54 instances where the indicator turned negative. In of the 54 cases the stock moved lower in the days that followed. This puts the odds of a downward move at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on January 20, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on RDNT as a result. In of 85 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

RDNT moved below its 50-day moving average on January 12, 2026 date and that indicates a change from an upward trend to a downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where RDNT declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

RDNT broke above its upper Bollinger Band on January 06, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Bullish Trend Analysis

The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 2 days, which means it's wise to expect a price bounce in the near future.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where RDNT advanced for three days, in of 314 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 253 cases where RDNT Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock slightly better than average.

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. RDNT’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (5.126) is normal, around the industry mean (12.114). RDNT's P/E Ratio (1425.750) is considerably higher than the industry average of (121.202). RDNT's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (1.874). RDNT has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.016). P/S Ratio (2.717) is also within normal values, averaging (12.571).

View a ticker or compare two or three
RDNT
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. RDNT showed earnings on November 10, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information

General Information

a provider of medical imaging services

Industry MedicalSpecialties

Profile
Fundamentals
Details
Industry
Medical Or Nursing Services
Address
1510 Cotner Avenue
Phone
+1 310 478-7808
Employees
8441
Web
http://www.radnet.com